DEA Reviews Bulk Schedule I Drug Manufacturing Request
Published Date: 7/22/2026
Notice
Summary
Cerilliant Corporation wants to become an official bulk maker of some powerful controlled substances, mostly in Schedule I. This affects anyone involved in drug manufacturing or regulation, with a chance to comment or request a hearing by September 21, 2026. No direct costs are mentioned, but the decision could impact how these substances are produced and controlled.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-14286, Importer of Controlled Substances Application: Catalent Greenville, Inc.
Catalent Greenville, Inc. wants to become an official importer of some powerful controlled substances, including LSD and related drugs. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 17, 2026. This move could impact how these substances enter the U.S., but no costs or fees are mentioned yet.
2026-14137, Shane Lydon, M.D.; Decision and Order
Dr. Shane Lydon's license to handle controlled substances in Maine has been revoked because he lost his state authority and didn’t ask for a hearing. This means he can no longer prescribe or manage these drugs, effective immediately. Anyone relying on his registration should update their records and note this change to avoid legal trouble.
2026-14135, David Enright, M.D.; Decision and Order
Dr. David Enright from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-14136, Barlow St-Clair Lynch, M.D.; Decision and Order
Dr. Barlow St-Clair Lynch from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately, impacting his medical practice and any related income.
Previous / Next Documents
Previous: 2026-14703, Personnel Demonstration Project at the United States Army Communications-Electronics Command Software Engineering Center Science and Technology Reinvention Laboratory (STRL)
The Army’s Software Engineering Center is updating its personnel rules to give employees more flexibility and better ways to manage their jobs. This change affects workers at the Communications-Electronics Command and aims to keep things running smoothly after recent reorganizations. The new plan won’t start until after a 30-day comment period ending August 21, 2026, so everyone has a chance to weigh in.
Next: 2026-14705, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Advanced Nursing Education Program Specific Form OMB No. 0906-0089-Revision
HRSA is updating its Advanced Nursing Education Program form by removing the part-time option for Nurse Midwife and Nurse Anesthetist trainees since only full-time students qualify now. This change affects schools and students in master’s and doctoral nursing programs and aims to simplify reporting. Public comments are open until September 21, 2026, so get your thoughts in before then!